Not available
Quote | Atossa Therapeutics Inc. (NASDAQ:ATOS)
Last: | $1.7501 |
---|---|
Change Percent: | 5.43% |
Open: | $1.69 |
Close: | $1.66 |
High: | $1.78 |
Low: | $1.67 |
Volume: | 1,013,359 |
Last Trade Date Time: | 05/06/2024 03:00:00 am |
News | Atossa Therapeutics Inc. (NASDAQ:ATOS)
2024-04-29 09:32:57 ET More on Atossa Therapeutics Atossa stock climbs 11% on breast cancer drug data ATOS, SMR and EIGR are among pre market gainers Seeking Alpha’s Quant Rating on Atossa Therapeutics Historical earnings data for Atossa Therapeutics ...
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las Vegas, NV. Event website: https://planetmi...
Message Board Posts | Atossa Therapeutics Inc. (NASDAQ:ATOS)
Subject | By | Source | When |
---|---|---|---|
Wow. No comments? | killrEngineer | investorshub | 06/28/2023 2:55:37 PM |
MomentumIts trading | 4MVault | investorshub | 06/26/2023 2:08:03 PM |
$ATOS Lets go go go go... Up up and away we go. | DrHarleyboy | investorshub | 06/26/2023 10:09:55 AM |
$ATOS bears and bulls | DrHarleyboy | investorshub | 06/26/2023 1:31:57 AM |
$ATOS MomentumIts gaining | willlbone | investorshub | 06/25/2023 2:39:32 AM |
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company") today announced an expanded rese...
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las Vegas, NV. Event website: https://planetmi...
SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced an expanded research agreement with Weill Cornell Medicine to explore the potential synergy between antibody drug conjugates (ADCs) and (Z)-...